Modulation of multidrug efflux pump activity by new hydantoin derivatives on colon adenocarcinoma cells without inducing apoptosis

Anticancer Research

Volumn 31, Issue 10, 2011, Pages 3285-3288

  Spengler, Gabriella ^a,b,c   Handzlik, Jadwiga ^d   Ocsovszki, Imre ^a   Viveiros, Miguel ^a,e   Kieć Kononowicz, Katarzyna ^d   Molnar, Joseph ^a,e   Amaral, Leonard ^a,b,c,e  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^c INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

^d JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^e EUROPEAN COMMISSION   (Belgium)

Author keywords

ABCB1 transporter; Apoptosis; Colo 205 and Colo 320 colon adenocarcinoma cells; Efflux pump; Hydantoin derivatives; Multidrug resistance

Indexed keywords

HYDANTOIN DERIVATIVE; MULTIDRUG RESISTANCE PROTEIN 1; RHODAMINE 123;

APOPTOSIS; ARTICLE; CANCER CELL; COLON ADENOCARCINOMA; CONTROLLED STUDY; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG EFFICACY; HUMAN; HUMAN CELL; IC 50; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; HUMANS; HYDANTOINS; MICE; P-GLYCOPROTEIN; RHODAMINE 123;

EID: 80054745363     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Rodgers TR, LaMontagne MP, Markovac A and Ash AB: Hydantoins as antitumor agents. J Med Chem 20(4): 591-594, 1977. (Pubitemid 8065725)
2. Carmi C, Cavazzoni A, Zuliani V, Lodola A, Bordi F, Plazzi PV, Alfieri RR, Petronini PG and Mor M: 5-Benzylidene-hydantoins as new EGFR inhibitors with antiproliferative activity. Bioorg Med Chem Lett 16(15): 4021-4025, 2006. (Pubitemid 43903211)
3. Zuliani V, Carmi C, Rivara M, Fantini M, Lodola A, Vacondio F, Bordi F, Plazzi PV, Cavazzoni A, Galetti M, Alfieri RR, Petronini PG and Mor M: 5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line. Eur J Med Chem 44(9): 3471-3479, 2009.
4. Iczkowski KA: Cell adhesion molecule CD44: its functional roles in prostate cancer. Am J Transi Res 3(1): 1-7, 2010.
5. Khanfar MA, Asal BA, Mudit M, Kaddoumi A and El Sayed KA: The marine natural-derived inhibitors of glycogen synthase kinase-3beta phenylmethylene hydantoins: in vitro and in vivo activities and pharmacophore modeling. Bioorg Med Chem 17(16): 6032-6039, 2009.
6. Lee TS, Chen LC, Liu Y, Wu J, Liang YC and Lee WS: 5,5-Diphenyl-2- thiohydantoin-N10 (DPTH-N10) suppresses proliferation of cultured colon cancer cell line COLO-205 by inhibiting DNA synthesis and activating apoptosis. Naunyn Schmiedebergs Arch Pharmacol 382(1): 43-50, 2010.
7. Ananda Kumar CS, Prasad SB, Vinaya K, Chandrappa S, Thimmegowda NR, Ranganatha SR, Swarup S and Rangappa KS: Synthesis and antiproliferative activity of substituted diazaspiro hydantoins: a structure-activity relationship study. Invest New Drugs 27(2): 131-139, 2009.
8. Spengler G, Evaristo M, Handzlik J, Serly J, Molnár J, Viveiros M, Kieć-Kononowicz K and Amaral L: Biological activity of hydantoin derivatives on P-glycoprotein (ABCB1) of mouse lymphoma cells. Anticancer Res 30(12): 4867-4871, 2010.
9. Pétriz J and García-López J: Flow cytometric analysis of P-glycoprotein function using rhodamine 123. Leukemia 11: 1124-1130, 1997.
10. Gyemant N, Tanaka M, Molnar P, Deli J, Mandoky L and Molnar J: Reversal of multidrug resistance of cancer cells in vitro: modification of drug resistance by selected carotenoids. Anticancer Res 26: 367-374, 2006. (Pubitemid 43206100)
11. Ugocsai K, Varga A, Molnár P, Antus S and Molnár J: Effects of selected flavonoids and carotenoids on drug accumulation and apoptosis induction in multidrug-resistant colon cancer cells expressing MDR1/LRP. In Vivo 19: 433-438, 2005. (Pubitemid 40467630)
12. Cavazzoni A, Alfieri RR, Carmi C, Zuliani V, Galetti M, Fumarola C, Frazzi R, Bonelli M, Bordi F, Lodola A, Mor M and Petronini PG: Dual mechanisms of action of the 5-benzylidcne-hydantoin UPR1024 on lung cancer cell lines. Mol Cancer Ther 7: 361-370, 2008. (Pubitemid 351302529)
13. Kavitha CV, Nambiar M, Ananda Kumar CS, Choudhary B, Muniyappa K, Rangappa KS and Raghavan SC: Novel derivatives of spirohydantoin induce growth inhibition followed by apoptosis in leukemia cells. Biochem Pharmacol 77(3): 348-363, 2009.
14. Subtel'na I, Atamanyuk D, Szymańska E, Kieć-Kononowicz K, Zimenkovsky B, Vasylenko O, Gzella A and Lesyk R: Synthesis of 5-arylidene-2-amino-4-azolones and evaluation of their anticancer activity. Bioorg Med Chem 18(14): 5090-5102, 2010.